Revised SPCs: Nplate (romiplostim) powder for solution for injection – all strengths and products

SPC revised to include license extension for treatment of chronic primary immune thrombocytopenia in paediatric patients’ ≥ 1 year of age refractory to other treatments (e.g. corticosteroids, immunoglobulins)

Source:

electronic Medicines compendium